Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion type Assertion NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_head.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion evidence source_evidence_literature NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion SIO_000772 23734683 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion wasDerivedFrom befree-20150227 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion wasGeneratedBy ECO_0000203 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.